Business

Novo Nordisk Stock Plummets on Investor Disappointment

Updated 2026-09-21 09:10 UTC 1 source Negative

Novo Nordisk stock saw a significant drop after the company failed to impress investors with its 2030 goals for its weight-loss drug Ozempic. The decline reflects investor concerns over the company's ability to maintain growth.

Coverage timeline — 1 article

MarketWatch

Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.

2026-09-21 08:58 UTC